Capital Ideas
Morning NoteGet Premium

READ THE LATEST MORNING NOTE

A MODEL GROWTH BY ACQUISITION COMPANY

Today’s new Digest features a company that has the growth by acquisition model down pat with a 3,000%+ stock gain the last 15 years.


INITIATIONS ON DOCEBO, K92 MINING & RUBICON ORGANICS


UPGRADES, DOWNGRADES & CANNABIS WOES CONTINUE


S&P 500 POISED FOR RECORD AMID EARNINGS FLOOD


MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH

Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.


CELEBRITY FACTOR DRIVING THIS RETAIL STOCK

What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.


MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK

We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.


MICROSOFT GETS TARGET BOOST AS IT BEATS FAANGs



Error X
Your e-mails don't match.
Close